Kristina Jenkins

Kristina Jenkins supports the National Institute on Drug Abuse (NIDA) in advancing scientific research through strategic procurement of high-impact scientific and technical services. She manages a portfolio of research-focused acquisitions aligned with NIDA’s mission to translate neurobiological and behavioral findings into clinical and public health applications. Her work centers on securing specialized laboratory instrumentation, analytical services, and R&D support critical to substance use disorder research, ensuring compliance with federal acquisition regulations and scientific rigor. She routinely handles complex, multi-year contracts requiring technical evaluation and performance-based management to support federally funded studies across academic and research institutions. Jenkins maintains longstanding partnerships with leading academic medical centers, including McLean Hospital Corporation, the University of Maryland Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These institutions serve as primary recipients of research contracts, providing expertise in clinical trials, neuroimaging, behavioral analytics, and pharmacological studies. Her contracting approach emphasizes collaborative, mission-aligned partnerships with institutions possessing deep domain expertise in addiction science, prioritizing scientific merit and translational potential over cost alone. Her procurement patterns reflect a strong preference for open competition, with 95.8% of awards issued without set-aside restrictions, indicating a focus on selecting the most qualified entities regardless of size or socioeconomic designation. While small business participation is limited to 4.2% of awards, primarily under Total Small Business Set-Asides, her approach remains compliant with FAR 19.5 while prioritizing scientific capability and research infrastructure. Jenkins’ primary NAICS focus includes Analytical Laboratory Instrument Manufacturing (334516) and Professional, Scientific, and Technical Services (541990), reflecting her emphasis on advanced instrumentation, data analytics, and R&D services in life sciences. She frequently procures electromedical devices, research-grade analytical equipment, and biotechnology R&D support, demonstrating specialized expertise in the technical infrastructure required for cutting-edge addiction science.